Latest filing published 25 Jul 2022 for Marvel Biosciences Corp. Formerly Alphanco Venture Corp..
No signal scores available.
All filings by Harpreet Nijjar on record concern Marvel Biosciences Corp. Formerly Alphanco Venture Corp. Over a trading history stretching from 1 February 2022 to 19 July 2022, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 25 July 2022 with a transaction in Marvel Biosciences Corp. Formerly Alphanco Venture Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations